Morgan Stanley Cryo Cell International Inc Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Cryo Cell International Inc stock. As of the latest transaction made, Morgan Stanley holds 600 shares of CCEL stock, worth $4,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600
Previous 601
0.17%
Holding current value
$4,500
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CCEL
# of Institutions
16Shares Held
920KCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$3.07 Million3.11% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$1.24 Million0.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA117KShares$876,3600.0% of portfolio
-
Massmutual Trust CO Fsb111KShares$832,7620.02% of portfolio
-
Geode Capital Management, LLC Boston, MA39.9KShares$298,9500.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $63.9M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...